Peter Barton Hutt's Net Worth
$8.18 Million
Who is Peter Barton Hutt?
Peter Barton Hutt has an estimated net worth of $8.18 Million. This is based on reported shares across multiple companies, which include Moderna, Inc., IMMUNOMEDICS INC, BIND Therapeutics, Inc, Q Holdings, Inc., Celera CORP, XOMA LTD /DE/, Seres Therapeutics, Inc., CONCERT PHARMACEUTICALS, INC., SELECTA BIOSCIENCES INC, Flex Pharma, Inc., MOMENTA PHARMACEUTICALS INC, ISTA PHARMACEUTICALS INC, Phase Forward Inc, MMR Information Systems, Inc., INTROGEN THERAPEUTICS INC, QUICK MED TECHNOLOGIES INC, and CV THERAPEUTICS INC.
SEC CIK
Peter Barton Hutt's CIK is 0001171527
Past Insider Trading and Trends
2006 was Peter Barton Hutt's most active year for acquiring shares with 9 total transactions. Peter Barton Hutt's most active month to acquire stocks was the month of May. 2012 was Peter Barton Hutt's most active year for disposing of shares, totalling 11 transactions. Peter Barton Hutt's most active month to dispose stocks was the month of May. 2015 saw Peter Barton Hutt paying a total of $249,998.94 for 113,746 shares, this is the most they've acquired in one year. In 2019 Peter Barton Hutt cashed out on 607,078 shares for a total of $5,835,487.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$10.11 | -$4,028,000.00 | 3.92K |
Nov 20
| |||
Form 4
|
—
|
0
|
$8.83 | -$1,759,000.00 | 3.92K |
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNOMEDICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.52K |
—
|
—
|
0
|
Oct 23
| |||
Form 4
| +27.51% | 3.72K |
—
|
—
| 17.23K |
Jun 18
| |||
Form 4
| +251.16% | 9.67K |
—
|
—
| 13.52K |
Jun 7
| |||
Form 4
|
∞
| 3.85K |
—
|
—
| 3.85K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15K |
$0.44 | $6,600.00 | 15K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Q Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 32.45K |
$0.15 | $4,867.65 | 64.9K |
Jul 14 - Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celera CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||